Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20240412005Completed
Open-label, single-arm trial of propofol + remifentanil, sponsored by Department of Anesthesiology. Primary endpoint: Incidence of complications. Started Apr 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20240412005.